Open in App
  • Local
  • U.S.
  • Election
  • Politics
  • Crime
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • EurekAlert

    SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack

    16 hours ago
    Comments / 0
    Add a Comment
    YOU MAY ALSO LIKE
    Most Popular newsMost Popular
    Medical News Today2 days ago
    Medical News Today11 days ago
    Total Apex Sports & Entertainment6 days ago
    Medical News Today13 days ago

    Comments / 0